Back
Marker Therapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Sell
46
MRKR
Marker Therapeutics
Last Price:
3.28
Seasonality Move:
-1.19%
Buy
72
ARMP
Armata Pharmaceuticals
Last Price:
2.40
Seasonality Move:
7.03%
Sell
46
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $3.52. The Score for MRKR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- MRKR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.40. The Score for ARMP is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $3.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.40
The current trend is relatively stagnant and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRKR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 62.79 | Buy |
Chaikin Money Flow: | 34790 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.57 - 3.05) | Buy |
Bollinger Bands (100): | (2.93 - 4.81) | Sell |
ARMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 53.39 | Buy |
Chaikin Money Flow: | 2584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.23 - 2.39) | Buy |
Bollinger Bands (100): | (2.31 - 2.83) | Sell |
MRKR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.93 | Buy |
20-day SMA: | 2.82 | Buy |
50-day SMA: | 3.12 | Buy |
200-day SMA: | 4.11 | Sell |
8-day EMA: | 3.06 | Buy |
20-day EMA: | 2.93 | Buy |
50-day EMA: | 3.21 | Buy |
200-day EMA: | 3.84 | Sell |
ARMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.35 | Buy |
20-day SMA: | 2.33 | Buy |
50-day SMA: | 2.37 | Buy |
200-day SMA: | 2.96 | Sell |
8-day EMA: | 2.36 | Buy |
20-day EMA: | 2.34 | Buy |
50-day EMA: | 2.41 | Sell |
200-day EMA: | 2.68 | Sell |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Marker Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Armata Pharmaceuticals Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |